Literature DB >> 21645978

The role of RTX toxins in host specificity of animal pathogenic Pasteurellaceae.

Joachim Frey1.   

Abstract

RTX toxins are bacterial pore-forming toxins that are particularly abundant among pathogenic species of Pasteurellaceae, in which they play a major role in virulence. RTX toxins of several primary pathogens of the family of Pasteurellaceae are directly involved in causing necrotic lesions in the target organs. Many RTX toxins are known as haemolysins because they lyse erythrocytes in vitro, an effect that is non-specific, but which serves as a useful marker in bacteriological identification and as an easily measurable signal in vitro in experimental studies. More recent studies have shown that the specific targets of most RTX toxins are leukocytes, with RTX toxins binding to the corresponding β-subunit (CD18) of β2 integrins and then exerting cytotoxic activity. After uptake by the target cell, at sub-lytic concentrations, some RTX toxins are transported to mitochondria and induce apoptosis. For several RTX toxins the binding to CD18 has been shown to be host specific and this seems to be the basis for the host range specificity of these RTX toxins. Observations on two very closely related species of the Pasteurellaceae family, Actinobacillus suis, a porcine pathogen particularly affecting suckling pigs, and Actinobacillus equuli subsp. haemolytica, which causes pyosepticaemia in new-born foals (sleepy foal disease), have revealed that they express different RTX toxins, named ApxI/II and Aqx, respectively. These RTX toxins are specifically cytotoxic for porcine and equine leukocytes, respectively. Furthermore, the ApxI and Aqx toxins of these species, when expressed in an isogenetic background in Escherichia coli, are specifically cytotoxic for leukocytes of their respective hosts. These data indicate the determinative role of RTX toxins in host specificity of pathogenic species of Pasteurellaceae.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21645978     DOI: 10.1016/j.vetmic.2011.05.018

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  13 in total

1.  Monoclonal antibodies against Vibrio vulnificus RtxA1 elicit protective immunity through distinct mechanisms.

Authors:  Tae Hee Lee; Sun-Shin Cha; Chang-Seop Lee; Joon Haeng Rhee; Kyung Min Chung
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

Review 2.  Host specificity of bacterial pathogens.

Authors:  Andreas Bäumler; Ferric C Fang
Journal:  Cold Spring Harb Perspect Med       Date:  2013-12-01       Impact factor: 6.915

3.  Shotgun Proteomics of Ascidians Tunic Gives New Insights on Host-Microbe Interactions by Revealing Diverse Antimicrobial Peptides.

Authors:  Ana Matos; Dany Domínguez-Pérez; Daniela Almeida; Guillermin Agüero-Chapin; Alexandre Campos; Hugo Osório; Vitor Vasconcelos; Agostinho Antunes
Journal:  Mar Drugs       Date:  2020-07-13       Impact factor: 5.118

Review 4.  The RTX pore-forming toxin α-hemolysin of uropathogenic Escherichia coli: progress and perspectives.

Authors:  Travis J Wiles; Matthew A Mulvey
Journal:  Future Microbiol       Date:  2013-01       Impact factor: 3.165

5.  Draft Genome Sequence of Chelonobacter oris Strain 1662T, Associated with Respiratory Disease in Hermann's Tortoises.

Authors:  Egle Kudirkiene; Mie Johanne Hansen; Anders Miki Bojesen
Journal:  Genome Announc       Date:  2014-12-18

6.  Membrane-Pore Forming Characteristics of the Bordetella pertussis CyaA-Hemolysin Domain.

Authors:  Chattip Kurehong; Chalermpol Kanchanawarin; Busaba Powthongchin; Gerd Katzenmeier; Chanan Angsuthanasombat
Journal:  Toxins (Basel)       Date:  2015-04-30       Impact factor: 4.546

7.  A computational strategy for the search of regulatory small RNAs in Actinobacillus pleuropneumoniae.

Authors:  Ciro C Rossi; Janine T Bossé; Yanwen Li; Adam A Witney; Kate A Gould; Paul R Langford; Denise M S Bazzolli
Journal:  RNA       Date:  2016-07-11       Impact factor: 4.942

8.  In vivo testing of novel vaccine prototypes against Actinobacillus pleuropneumoniae.

Authors:  Fabio Antenucci; Cyrielle Fougeroux; Alannah Deeney; Cathrine Ørskov; Andrew Rycroft; Peter Johannes Holst; Anders Miki Bojesen
Journal:  Vet Res       Date:  2018-01-09       Impact factor: 3.683

9.  Pathogenic variability among Pasteurella multocida type A isolates from Brazilian pig farms.

Authors:  João Xavier de Oliveira Filho; Marcos Antônio Zanella Morés; Raquel Rebellato; Jalusa Deon Kich; Maurício Egidio Cantão; Catia Silene Klein; Roberto Maurício Carvalho Guedes; Arlei Coldebella; David Emílio Santos Neves de Barcellos; Nelson Morés
Journal:  BMC Vet Res       Date:  2018-08-22       Impact factor: 2.741

10.  Construction and immunization with double mutant ΔapxIBD Δpnp forms of Actinobacillus pleuropneumoniae serotypes 1 and 5.

Authors:  Hoai Thu Dao; Quang Lam Truong; Van Tan Do; Tae Wook Hahn
Journal:  J Vet Sci       Date:  2020-03       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.